Difference between revisions of "Escitalopram-doxepine"

From Psychiatrienet
Jump to: navigation, search
(Redirected page to Citalopram-doxepine)
 
Line 1: Line 1:
#redirect [[citalopram-doxepine]]
+
{{Drugswitch
 +
| from = escitalopram
 +
| to = doxepin
 +
| stop = {{StopEscitalopram}}
 +
| start =
 +
* '''Day 8:''' start administration of doxepin in a normal dosage of 25 mg/day.
 +
* '''Day 15:''' increase dosage of doxepin.
 +
| info =
 +
* {{theorSS}}
 +
}}

Revision as of 23:00, 4 March 2010

Escitalopram
Type Antidepressant
Group SSRI
links
Medscape Escitalopram
PubChem 10832572
PubMed Escitalopram
Kompas (Dutch) Escitalopram
Wikipedia Escitalopram
Doxepin
Type antidepressant
Group TCA
links
ATC-code N06AA12
Medscape Doxepin
PubChem 3158
PubMed Doxepin
Drugs.com doxepin
Kompas (Dutch) Doxepin
Wikipedia Doxepin

Switch medication from escitalopram to doxepin.

Nietinrijdenbord.png Stop escitalopram
  • Before day 1: gradually reduce dosage of escitalopram to a maximum of 10 mg/day, when this dosage is >10 mg/day.
  • Day 1: reduce dosage of escitalopram to a maximum of 5 mg/day.
  • Day 8: stop administration of escitalopram.
Eenrichtingbord.png Start doxepin
  • Day 8: start administration of doxepin in a normal dosage of 25 mg/day.
  • Day 15: increase dosage of doxepin.
Infobord.png More information
  • Occurrence of the serotonin syndrome is not likely, but theoretically possible, so caution is necessary.
  1. 1.0 1.1 1.2 1.3 1.4 KNMP; Informatorium Medicamentorum 2015; Monografie "doxepine" (Dutch)
  2. NVZA; Toxicology.org; Monografie 63 (dutch)
The editors of psychiatrienet.nl take the greatest care to provide up-to-date and accurate information on this site. Nevertheless, mistakes and omissions cannot be entirely excluded. No rights devolve from the information provided. The editors and other providers of information to this site accept no responsibility for the content of this site or for the information provided therein; neither do they accept responsibility for possible damages which may derive from the use of the information on this site or from the linked sites. The editorial board accepts no responsibility for the content of the (linked) sites, for access to them, or for the products and services on these sites, nor for the occurrence of errors, viruses, and/or disruptions in service.